Efficacy and Safety of Tranexamic Acid in Cancer Surgery. An Update of Clinical Findings and Ongoing Research

References

• Johnstone C, Rich SE. Bleeding in cancer patients and its treatment: a review. Ann Palliat Med. 2018;7(2):265–273. doi:10.21037/apm.2017.11.01
   PubMed Web of Science ®Google Scholar
• Cata JP, Gottumukkala V. Blood transfusion practices in cancer surgery. Indian J Anaesth. 2014;58(5):637–642. doi:10.4103/0019-5049.144675
   PubMedGoogle Scholar
• Kim HJ, Moon SH, Cho SH, Lee JD, Kim HS. Efficacy and safety of tranexamic acid in melasma: a meta-analysis and systematic review. Acta Derm Venereol. 2017;97(7):776–781. doi:10.2340/00015555-2668
   PubMed Web of Science ®Google Scholar
• Leebeek FW, Rijken DC. The fibrinolytic status in liver diseases. Semin Thromb Hemost. 2015;41(5):474–480. doi:10.1055/s-0035-1550437
   PubMed Web of Science ®Google Scholar
• Abeysiri S, Chau M, Richards T. Perioperative anemia management. Semin Thromb Hemost. 2020;46(1):8‑16.
   PubMed Web of Science ®Google Scholar
• Ramsey G, Lindholm PF. Thrombosis risk in cancer patients receiving red blood cell transfusions. Semin Thromb Hemost. 2019;45(6):648‑56.
   PubMed Web of Science ®Google Scholar
• Goel R, Patel EU, Cushing MM, et al. Association of perioperative red blood cell transfusions with venous thromboembolism in a North American registry. JAMA Surg. 2018;153(9):826‑33. doi:10.1001/jamasurg.2018.1565
   PubMed Web of Science ®Google Scholar
• Oliveira GSD, Schink JC, Buoy C, Ahmad S, Fitzgerald PC, McCarthy RJ. The association between allogeneic perioperative blood transfusion on tumour recurrence and survival in patients with advanced ovarian cancer. Transfus Med. 2012;22(2):97‑103. doi:10.1111/j.1365-3148.2011.01122.x
   Web of Science ®Google Scholar
• Schiergens TS, Rentsch M, Kasparek MS, Frenes K, Jauch K-W, Thasler WE. Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases. Dis Colon Rectum. 2015;58(1):74‑82. doi:10.1097/DCR.0000000000000233
   PubMed Web of Science ®Google Scholar
• Chang KY, Tai Y-H, Lin S-P, Chan M-Y, Chen -H-H, Chang K-Y. The impact of blood transfusion on recurrence and mortality following colorectal cancer resection: a propensity score analysis of 4030 patients. Sci Rep. 2018;8(1):13345. doi:10.1038/s41598-018-31662-5
   PubMed Web of Science ®Google Scholar
• Hallet J, Tsang M, Cheng ESW, et al. The impact of perioperative red blood cell transfusions on long-term outcomes after hepatectomy for colorectal liver metastases. Ann Surg Oncol. 2015;22(12):4038‑45. doi:10.1245/s10434-015-4477-4
   PubMed Web of Science ®Google Scholar
• Pushan Z, Manbiao C, Sulai L, Jun L, Ruidong Z, Hanshen Y. The impact of perioperative blood transfusion on survival and recurrence after radical prostatectomy for prostate cancer: a systematic review and meta-analysis. J Cancer Res Ther. 2018;14(Supplement):S701‑7.
   PubMedGoogle Scholar
• Ay C, Pabinger I, Cohen AT. Cancer-associated venous thromboembolism: burden, mechanisms, and management. Thromb Haemost. 2017;117(2):219‑30.
   Web of Science ®Google Scholar
• Laridan E, Martinod K, Meyer SFD. Neutrophil extracellular traps in arterial and venous thrombosis. Semin Thromb Hemost. 2019;45(1):86‑93. doi:10.1055/s-0038-1677040
   PubMed Web of Science ®Google Scholar
• Belghasem M, Roth D, Richards S, et al. Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor–tissue factor axis. Blood. 2019;134(26):2399‑413. doi:10.1182/blood.2019001675
   PubMed Web of Science ®Google Scholar
• Kulkarni AP, Chaukar DA, Patil VP, Metgudmath RB, Hawaldar RW, Divatia JV. Does tranexamic acid reduce blood loss during head and neck cancer surgery? Indian J Anaesth. 2016;60(1):19‑24. doi:10.4103/0019-5049.174798
   Google Scholar
• Ng W, Jerath A, Wąsowicz M. Tranexamic acid: a clinical review. Anaesthesiol Intensive Ther. 2015;47(4):339–350. doi:10.5603/AIT.a2015.0011
   PubMed Web of Science ®Google Scholar
• Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344:e3054. doi:10.1136/bmj.e3054
   PubMed Web of Science ®Google Scholar
• Cai J, Ribkoff J, Olson S, et al. The many roles of tranexamic acid: an overview of the clinical indications for TXA in medical and surgical patients. Eur J Haematol. 2020;104(2):79‑87. doi:10.1111/ejh.13348
   PubMed Web of Science ®Google Scholar
• Barrett CD, Vigneshwar N, Moore HB, et al. Tranexamic acid is associated with reduced complement activation in trauma patients with hemorrhagic shock and hyperfibrinolysis on thromboelastography. Blood Coagul Fibrinolysis. 2020;31(8):578–582. doi:10.1097/MBC.0000000000000938
   PubMed Web of Science ®Google Scholar
• Shakur H, Roberts I, Bautista R, et al.; CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23–32. doi:10.1016/S0140-6736(10)60835-5
   PubMed Web of Science ®Google Scholar
• Suojanen J, Sorsa T, Salo T. Tranexamic acid can inhibit tongue squamous cell carcinoma invasion in vitro. Oral Dis. 2009;15(2):170–175. doi:10.1111/j.1601-0825.2008.01507.x
   PubMed Web of Science ®Google Scholar
• Shakur H, Beaumont D, Pavord S, Gayet‐Ageron A, Ker K, Mousa HA. Antifibrinolytic drugs for treating primary postpartum haemorrhage. Cochrane Database Syst Rev. 2018;2018(2):CD012964.
   Google Scholar
• Sentilhes L, Winer N, Azria E, et al.; Groupe de Recherche en Obstétrique et Gynécologie. Tranexamic acid for the prevention of blood loss after vaginal delivery. N Engl J Med. 2018;379(8):731–742. doi:10.1056/NEJMoa1800942
   PubMed Web of Science ®Google Scholar
• Balík M, Košina J, Hušek P, Broďák M, Čečka F. Safety and efficacy of using tranexamic acid at the beginning of robotic-assisted radical prostatectomy in a double-blind prospective randomized pilot study. Acta Medica. 2020;63(4):176‑82.
   Google Scholar
• Breau RH, Lavallée LT, Cnossen S, et al. Tranexamic acid versus placebo to prevent blood transfusion during radical cystectomy for bladder cancer (TACT): study protocol for a randomized controlled trial. Trials. 2018;19(1):261. doi:10.1186/s13063-018-2626-3
   PubMed Web of Science ®Google Scholar
• Claeys MA, Vermeersch N, Haentjens P. Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chir Belg. 2007;107(4):397‑401.
   PubMed Web of Science ®Google Scholar
• Alanwar A, Abbas AM, Hussain SH, et al. Oral micronised flavonoids versus tranexamic acid for treatment of heavy menstrual bleeding secondary to copper IUD use: a randomised double-blind clinical trial. Eur J Contracept Reprod Health Care. 2018;23(5):365–370. doi:10.1080/13625187.2018.1515349
   PubMed Web of Science ®Google Scholar
• Hoste S, Van Aken H, Stevens E. Tranexamic acid in the treatment of anaphylactic shock. Acta Anaesthesiol Belg. 1991;42(2):113–116.
   PubMedGoogle Scholar
• Chen CC, Wang CC, Wang CP, Lin TH, Lin WD, Liu SA. Prospective, randomized, controlled trial of tranexamic acid in patients who undergo head and neck procedures. Otolaryngol Head Neck Surg. 2008;138(6):762–767. doi:10.1016/j.otohns.2008.02.022
   PubMed Web of Science ®Google Scholar
• Crescenti A, Borghi G, Bignami E, et al. Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial. BMJ. 2011;343:d5701. doi:10.1136/bmj.d5701
   PubMed Web of Science ®Google Scholar
• Pourfakhr P, Gatavi E, Gooran S, et al. Local administration of tranexamic acid during prostatectomy surgery: effects on reducing the amount of bleeding. Nephro Urol Mon. 2016;8(6):e40409. doi:10.5812/numonthly.40409
   PubMedGoogle Scholar
• Jendoubi A, Malouch A, Bouzouita A, et al. Intérêt de l’acide tranexamique dans les résections endoscopiques urologiques: étude prospective randomisée [Safety and efficacy of intravenous tranexamic acid in endoscopic transurethral resections in urology: prospective randomized trial]. Prog Urol. 2017;27(16):1036–1042. French. doi:10.1016/j.purol.2017.09.008
   PubMed Web of Science ®Google Scholar
• Meng -Q-Q, Pan N, Xiong J-Y, Liu N. Tranexamic acid is beneficial for reducing perioperative blood loss in transurethral resection of the prostate. Exp Ther Med. 2019;17(1):943‑7.
   Web of Science ®Google Scholar
• Mirmansouri A, Farzi F, Imantalab V, et al. A survey on the effects of intravenous tranexamic acid on the amount of transfusion in patients undergoing T.U.R-P. J Guilan Univ Med Sci. 2016;25(98):110‑6.
   Google Scholar
• Miller RA, May MW, Hendry WF, Whitfield HN, Wickham JE. The prevention of secondary haemorrhage after prostatectomy: the value of antifibrinolytic therapy. Br J Urol. 1980;52(1):26‑8. doi:10.1111/j.1464-410X.1980.tb02914.x
   Google Scholar
• Longo MA, Cavalheiro BT, de Oliveira Filho GR. Systematic review and meta-analyses of tranexamic acid use for bleeding reduction in prostate surgery. J Clin Anesth. 2018;48:32–38. doi:10.1016/j.jclinane.2018.04.014
   PubMed Web of Science ®Google Scholar
• Rannikko A, Pétas A, Taari K. Tranexamic acid in control of primary hemorrhage during transurethral prostatectomy. Urology. 2004;64(5):955‑8. doi:10.1016/j.urology.2004.07.008
   PubMed Web of Science ®Google Scholar
• Samir M, Saafan AM, Afifi RM, Tawfick A. Can high-dose tranexamic acid have a role during transurethral resection of the prostate in large prostates? A randomised controlled trial. Arab J Urol. 2021;20:24–29. doi:10.1080/2090598X.2021.1932125
   PubMed Web of Science ®Google Scholar
• Oka K, Tsuda H, Kamikaseda K, et al. Meningiomas and hemorrhagic diathesis. J Neurosurg. 1988;69(3):356–360. doi:10.3171/jns.1988.69.3.0356
   PubMed Web of Science ®Google Scholar
• Goh KYC, Poon WS, Chan DTM, Ip CP. Tissue plasminogen activator expression in meningiomas and glioblastomas. Clin Neurol Neurosurg. 2005;107(4):296‑300. doi:10.1016/j.clineuro.2004.09.010
   PubMed Web of Science ®Google Scholar
• Vel R, Udupi BP, Satya Prakash MVS, Adinarayanan S, Mishra S, Babu L. Effect of low dose tranexamic acid on intra-operative blood loss in neurosurgical patients. Saudi J Anaesth. 2015;9(1):42‑8. doi:10.4103/1658-354X.159469
   PubMedGoogle Scholar
• Hooda B, Chouhan RS, Rath GP, Bithal PK, Suri A, Lamsal R. Effect of tranexamic acid on intraoperative blood loss and transfusion requirements in patients undergoing excision of intracranial meningioma. J Clin Neurosci. 2017;41:132‑8. doi:10.1016/j.jocn.2017.02.053
   PubMed Web of Science ®Google Scholar
• Bednar DA, Bednar VA, Chaudhary A, Farroukhyar F. Tranexamic acid for hemostasis in the surgical treatment of metastatic tumors of the spine. Spine. 2006;31(8):954‑7. doi:10.1097/01.brs.0000209304.76581.c5
   PubMed Web of Science ®Google Scholar
• Damade C, Tesson G, Gilard V, et al. Blood loss and perioperative transfusions related to surgery for spinal tumors. Relevance of tranexamic acid. Neurochirurgie. 2019;65(6):377‑81. doi:10.1016/j.neuchi.2019.05.003
   PubMed Web of Science ®Google Scholar
• Zhang HZ, Dong L, Wang HM, et al. Safety and efficacy of tranexamic acid in spinal canal tumors: a retrospective cohort study. Br J Neurosurg. 2020;34(3):313‑5. doi:10.1080/02688697.2020.1717442
   Web of Science ®Google Scholar
• Wong J, El Beheiry H, Rampersaud YR, et al. Tranexamic acid reduces perioperative blood loss in adult patients having spinal fusion surgery. Anesth Analg. 2008;107(5):1479‑86. doi:10.1213/ane.0b013e3181831e44
   Web of Science ®Google Scholar
• Wu -C-C, Ho W-M, Cheng S-B, et al. Perioperative parenteral tranexamic acid in liver tumor resection. Ann Surg. 2006;243(2):173‑80. doi:10.1097/01.sla.0000197561.70972.73
   PubMed Web of Science ®Google Scholar
• Grass F, Braafladt S, Alabbad J, et al. The effects of tranexamic acid on blood loss and transfusion rate in colorectal surgery. Am J Surg. 2019;218(5):876‑80. doi:10.1016/j.amjsurg.2019.03.013
   PubMed Web of Science ®Google Scholar
• Wright GP, Wolf AM, Waldherr TL, et al. Preoperative tranexamic acid does not reduce transfusion rates in major oncologic surgery: results of a randomized, double-blind, and placebo-controlled trial. J Surg Oncol. 2020;122(6):1037‑42. doi:10.1002/jso.26142
   Web of Science ®Google Scholar
• Ishii K, Yokoyama Y, Yonekawa Y, Ebata T. Tranexamic ACid during PancereaticoDuodenectomy (TAC-PD): study protocol for a multicentre randomised, blind, placebo-controlled trial. BMJ Open. 2020;10(11):e040914. doi:10.1136/bmjopen-2020-040914
   PubMed Web of Science ®Google Scholar
• Abdul IF, Amadu MB, Adesina KT, Olarinoye AO, Omokanye LO. Adjunctive use of tranexamic acid to tourniquet in reducing haemorrhage during abdominal myomectomy - a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2019;242:150–158. doi:10.1016/j.ejogrb.2019.09.010
   PubMed Web of Science ®Google Scholar
• Celebi N, Celebioglu B, Selcuk M, Canbay O, Karagoz AH, Aypar U. The role of antifibrinolytic agents in gynecologic cancer surgery. Saudi Med J. 2006;27(5):637‑41.
   Web of Science ®Google Scholar
• Lundin ES, Johansson T, Zachrisson H, et al. Single-dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: double-blind placebo-controlled randomized multicenter study. Acta Obstet Gynecol Scand. 2014;93(4):335–344. doi:10.1111/aogs.12333
   PubMed Web of Science ®Google Scholar
• Kietpeerakool C, Supoken A, Laopaiboon M, Lumbiganon P. Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancer. Cochrane Database Syst Rev. 2016;2016(1):CD011732. doi:10.1002/14651858.CD011732.pub2
   PubMed Web of Science ®Google Scholar
• Weissler JM, Banuelos J, Jacobson SR, et al. Intravenous tranexamic acid in implant-based breast reconstruction safely reduces hematoma without thromboembolic events. Plast Reconstr Surg. 2020;146(2):238‑45. doi:10.1097/PRS.0000000000006967
   Web of Science ®Google Scholar
• Ausen K, Hagen AI, Østbyhaug HS, et al. Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial. BMJ Open. 2019;4(2):216‑24.
   Google Scholar
• Fillingham YA, Ramkumar DB, Jevsevar DS, et al. Tranexamic acid in total joint arthroplasty: the endorsed clinical practice guides of the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society. Reg Anesth Pain Med. 2019;44(1):7‑11.
   PubMed Web of Science ®Google Scholar
• Varady NH, Chen AF, Drayer NJ, Ready J, Lozano-Calderon SA, Hayden BL. Tranexamic acid in patients with current or former cancer undergoing Hip and knee arthroplasty. J Surg Oncol. 2021;123(8):1811‑20. doi:10.1002/jso.26448
   PubMed Web of Science ®Google Scholar
• Atalay İB, Yapar A, Ulucakoy C, et al. The effectiveness of tranexamic acid in patients with proximal femoral tumor resection prosthesis. Cureus. 2020;12(8):e10105. doi:10.7759/cureus.10105
   PubMed Web of Science ®Google Scholar
• Haase DR, Templeton KJ, Rosenthal HG, Sweeney KR. Tranexamic acid in patients with cancer undergoing endoprosthetic reconstruction: a retrospective review. JAAOS. 2020;28(6):248‑55. doi:10.5435/JAAOS-D-18-00798
   Google Scholar
• Owen A, Wellings EP, Wyles CC, Yuan BJ, Rose PS, Houdek MT. Use of tranexamic acid is not associated with complications following bipolar hemiarthroplasty for metastatic disease. J Surg Oncol. 2021;123(4):1121‑5. doi:10.1002/jso.26354
   PubMed Web of Science ®Google Scholar